Waldenström Macroglobulinemia - 2020 Update on Management and Future Directions

Clin Lymphoma Myeloma Leuk. 2020 Sep:20 Suppl 1:S39-S41. doi: 10.1016/S2152-2650(20)30456-0.

Author

Sheeba K Thomas¹

Affiliation

¹ University of Texas M. D. Anderson Cancer Center, 1515 Holcombe Boulevard, Unit 429, Houston, TX 77030, USA. Electronic address: [email protected].

PMID: 32862863
DOI: 10.1016/S2152-2650(20)30456-0

No abstract available

Keywords: BCL2 inhibitors; BTK inhibitors; Lymphoplasmacytic lymphoma; monoclonal antibodies; proteasome inhibitors.

MeSH terms

Humans
Waldenstrom Macroglobulinemia / diagnosis
Waldenstrom Macroglobulinemia / therapy*